1 |
RESPIRATORY-IMMUNODX Clinical validation of host biomarker signature for distinguishing bacterial versus viral lower respiratory tract infections (LRTI) in adults at the point-of-need |
2015 |
2˙935˙000.00 |
2˙935˙000.00 |
2 |
AUTOPILOT-DX Fast tracking market adoption of a novel immune-based diagnostic for improving antibiotic stewardship: automation, piloting and health economics |
2016 |
2˙923˙250.00 |
2˙293˙900.00 |
3 |
DECODE reDucing the health and Economic COst of Diagnostic uncErtainty: launch and randomized control trial of the first validated bacterial versus viral test |
2020 |
3˙571˙427.00 |
2˙499˙999.00 |